Marc Sim1, Brian Dawson2, Grant Landers2, Dorine W Swinkels3, Harold Tjalsma3, Bu B Yeap4, Debbie Trinder5, Peter Peeling2. 1. School of Sport Science, Exercise and Health, The University of Western Australia, Australia. Electronic address: marc.sim@uwa.edu.au. 2. School of Sport Science, Exercise and Health, The University of Western Australia, Australia. 3. Department of Laboratory Medicine, Laboratory of Genetic, Endocrine and Metabolic diseases, Radboud University Medical Centre, The Netherlands. 4. School of Medicine and Pharmacology, The University of Western Australia, Fremantle Hospital, Australia. 5. School of Medicine and Pharmacology, The University of Western Australia, Fremantle Hospital, Australia; Western Australian Institute for Medical Research, Australia.
Abstract
OBJECTIVES: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). DESIGN: Counterbalanced, repeated measures cross-over study. METHODS: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40 min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. RESULTS: In both trials, serum IL-6 was significantly elevated (p<0.05) immediately post-exercise, while serum hepcidin was significantly elevated (p<0.05) 3h post-exercise, with no significant differences recorded between trials. CONCLUSIONS: These findings suggest that exercise performed during the different phases (D-0 vs. D+7) of a monophasic OCP regulated cycle does not alter exercise induced IL-6 or hepcidin production. As such, future studies looking to investigate similar variables post-exercise, may not need to 'control' for different phases of the OCC, provided participants are current monophasic OCP users.
OBJECTIVES: The post-exercise interleukin-6 (IL-6) and hepcidin response was investigated during the hormone-deplete and hormone-replete phases of an estradiol and progestogen regulated oral contraceptive cycle (OCC). DESIGN: Counterbalanced, repeated measures cross-over study. METHODS: Ten active female monophasic oral contraceptive pill (OCP) users completed two 40 min treadmill running trials at 75% of their pre-determined peak oxygen uptake velocity (vVO2peak). These trials were randomly performed in two specific phases of the OCC: (a) Day 2-4, representing a hormone-free withdrawal period (D-0); (b) Day 12-14, representing the end of the first week of active hormone therapy (D+7). Venous blood samples were drawn pre-, post- and 3h post-exercise. RESULTS: In both trials, serum IL-6 was significantly elevated (p<0.05) immediately post-exercise, while serum hepcidin was significantly elevated (p<0.05) 3h post-exercise, with no significant differences recorded between trials. CONCLUSIONS: These findings suggest that exercise performed during the different phases (D-0 vs. D+7) of a monophasic OCP regulated cycle does not alter exercise induced IL-6 or hepcidin production. As such, future studies looking to investigate similar variables post-exercise, may not need to 'control' for different phases of the OCC, provided participants are current monophasic OCP users.
Authors: Marc Sim; Laura A Garvican-Lewis; Gregory R Cox; Andrew Govus; Alannah K A McKay; Trent Stellingwerff; Peter Peeling Journal: Eur J Appl Physiol Date: 2019-05-04 Impact factor: 3.078
Authors: Marc Sim; Brian Dawson; Grant J Landers; Dorine W Swinkels; Harold Tjalsma; Erwin T Wiegerinck; Debbie Trinder; Peter Peeling Journal: J Int Soc Sports Nutr Date: 2014-04-09 Impact factor: 5.150
Authors: Martina Zügel; Gunnar Treff; Jürgen M Steinacker; Benjamin Mayer; Kay Winkert; Uwe Schumann Journal: Front Physiol Date: 2020-01-21 Impact factor: 4.566
Authors: Ana B Peinado; Victor M Alfaro-Magallanes; Nuria Romero-Parra; Laura Barba-Moreno; Beatriz Rael; Cristina Maestre-Cascales; Miguel A Rojo-Tirado; Eliane A Castro; Pedro J Benito; Carmen P Ortega-Santos; Elena Santiago; Javier Butragueño; Antonio García-de-Alcaraz; Jesús J Rojo; Francisco J Calderón; Alberto García-Bataller; Rocío Cupeiro Journal: Int J Environ Res Public Health Date: 2021-01-16 Impact factor: 3.390
Authors: Víctor M Alfaro-Magallanes; Laura Barba-Moreno; Beatriz Rael; Nuria Romero-Parra; Miguel A Rojo-Tirado; Pedro J Benito; Dorine W Swinkels; Coby M Laarakkers; Ángel E Díaz; Ana B Peinado Journal: Scand J Med Sci Sports Date: 2020-12-07 Impact factor: 4.221